RGNT
RegentisยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About RGNT
Regentis Biomaterials Ltd.
An Israeli regenerative medicine company,using the Gelrin platform of biodegradable hydrogel implants to develop orthopedic tissue repair solutions
Healthcare Equipment and Supplies
--
12/04/2025
American Stock Exchange
3
12-31
Common stock
60 Medinat Hayehudim, Herzliya, Israel 4676652
--
Regentis Biomaterials Ltd., established in 2004, is located in Israel. Regentis Biomaterials Ltd., a regenerative medicine company, develops innovative tissue repair solutions to restore health and improve the quality of life of patients. The company's current efforts focus on orthopedic treatments, using the company's Gerlin platform based on biodegradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a unique hydrogel matrix consisting of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a bioinactivating protein that usually plays a role in blood coagulation). The company's lead product is GelrinC, a cell-free off-the-shelf hydrogel that solidifies into knee implants for the treatment of painful damage to articular cartilage.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
